Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Absolute risks are relatively low, but worth understanding before starting, especially for lifelong use
Participants must have active UC for at least 3 months with minimum 15cm disease extent from anal verge, inadequate response or intolerance to conventional treatments including amino-salicylates, corticosteroids, immunosuppressants or biologics, while excluding those with CD, indeterminate colitis, active infections, malignancies, or previous exposure to natalizumab or RIPK1 inhibitors
Preventing muscle loss with proper movement To effectively maintain muscle while taking GLP-1s, consistency matters more than intensity
As the popularization of this class of pharmaceuticals continues, specialists must stay aware of the known and unknown risks associated with their use
Although some users may experience temporary nausea and other reactions, its potential in addressing comorbidities such as joint pain related to obesity and sleep apnea is redefining the quality of life for patients with chronic metabolic diseases, and allowing long-term health management to go beyond the rigid dieting and frequent medication cycle
